In Focus

Patients fighting life-threatening illnesses who have run out of conventional options will get a chance to try some of the most cutting-edge treatments available, through a national effort that just received nearly $4.8 million in funding from the federal government.

Based at the University of Michigan, in partnership with Duke University, the University of Texas Southwestern Medical Center and the University of Rochester, the effort will build a national framework to help more patients gain access to experimental drugs, devices and biologics. It is funded by the National Center for Advancing Translational Sciences, part of the National Institutes of Health.

CBSSM News & Events

Reshma Jagsi & Andrew Barnosky are 2018 Dean's Award Recipients
CBSSM's Director, Reshma Jagsi, M.D., D.Phil., was selected to receive the 2017 Clinical and Health Services Research Award from the Dean's Awards program. Andrew R. Barnosky, D.O., MPH was awarded the Lifetime Achievement Award in Medical Education.
Read more.
Study finds Decision Support Tool "iCanDecide" Boosts Genetic Testing Knowledge In Breast Cancer Patients 10/08/2018
Michele Gornick, PhD is lead author on study that finds that a decision support tool "iCanDecide" boosts genetic testing knowledge in breast cancer patients. Co-authors include CBSSM's Reshma Jagsi, MD, DPhil and Sarah Hawley, PhD, MPH.
Read more.
Bioethics Grand Rounds -Barbara McQuade, JD 10/24/2018
"Law Enforcement Approaches to the Opioid Epidemic."
Read more.